| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |